Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H J Hageman

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Research and Practice in Thrombosis and Haemostasis|January 15, 2024
Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysisMaria A de Winter, Kednapa Thavorn, Steven H J Hageman, et al.
Heart (British Cardiac Society)|January 5, 2024
Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.
European Journal of Preventive Cardiology|June 20, 2023
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practiceSteven H J Hageman, Jannick A N Dorresteijn, Lisa Pennells, et al.
Obesity Research & Clinical Practice|December 4, 2022
Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Ynte M Ruigrok, et al.
Open Heart|April 23, 2022
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatmentMari Nordbø Gynnild, Steven H J Hageman, Olav Spigset, et al.
Heart (British Cardiac Society)|March 15, 2020
Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular diseaseSteven H J Hageman, Gert Jan de Borst, Johannes A N Dorresteijn, et al.
Clinical Epidemiology|September 27, 2021
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary PreventionMari Nordbø Gynnild, Steven H J Hageman, Jannick A N Dorresteijn, et al.
American Heart Journal|February 25, 2023
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.
Obesity Research & Clinical Practice|September 30, 2023
Effect of adipose tissue quantity and dysfunction on the risk of cancer in individuals with and without type 2 diabetesMarga A G Helmink, Jan Westerink, Steven H J Hageman, et al.
Journal of Clinical Epidemiology|July 17, 2024
Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysisSteven H J Hageman, Richard A J Post, Frank L J Visseren, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Research and Practice in Thrombosis and Haemostasis|January 15, 2024
Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysisMaria A de Winter, Kednapa Thavorn, Steven H J Hageman, et al.
Heart (British Cardiac Society)|January 5, 2024
Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.
European Journal of Preventive Cardiology|June 20, 2023
The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practiceSteven H J Hageman, Jannick A N Dorresteijn, Lisa Pennells, et al.
Obesity Research & Clinical Practice|December 4, 2022
Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Ynte M Ruigrok, et al.
Open Heart|April 23, 2022
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatmentMari Nordbø Gynnild, Steven H J Hageman, Olav Spigset, et al.
Heart (British Cardiac Society)|March 15, 2020
Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular diseaseSteven H J Hageman, Gert Jan de Borst, Johannes A N Dorresteijn, et al.
Clinical Epidemiology|September 27, 2021
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary PreventionMari Nordbø Gynnild, Steven H J Hageman, Jannick A N Dorresteijn, et al.
American Heart Journal|February 25, 2023
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular diseaseMaria C Castelijns, Steven H J Hageman, Martin Teraa, et al.
Obesity Research & Clinical Practice|September 30, 2023
Effect of adipose tissue quantity and dysfunction on the risk of cancer in individuals with and without type 2 diabetesMarga A G Helmink, Jan Westerink, Steven H J Hageman, et al.
Journal of Clinical Epidemiology|July 17, 2024
Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysisSteven H J Hageman, Richard A J Post, Frank L J Visseren, et al.
Pageof 4